Propranolol and cancer

Zehra Pınar Cengiz, Oytun Erbaş

DOI: 10.5606/fng.transplantasyon.2018.008

Issue: 2018, Volume 3 - Issue 1-2
0 2247

Relationship of sleep, melatonin, and cancer

Ali Çimen, Yasemin Akbaş, Oytun Erbaş

DOI: 10.5606/fng.transplantasyon.2018.009

Issue: 2018, Volume 3 - Issue 1-2
0 3859

Natural health products that inhibit tumoral angiogenesis

Emin Taşkıran, Harun Akar, Oytun Erbaş

DOI: 10.5606/fng.transplantasyon.2017.001

Issue: 2017, Volume 2 - Issue 1
0 1649

Solid organ transplantation and vascularized composite allotransplantation: Past and present

Burak Sercan Erçin, Kubilay Doğan Kılıç, Yiğit Özer Tiftikçioğlu, Ahmet Biçer, Yiğit Uyanıkgil, Alessandro Thione, Tahir Gürler

DOI: 10.5606/fng.transplantasyon.2017.002

Issue: 2017, Volume 2 - Issue 1
0 1705

Cancer immunotherapy

Ahmet Anıl Özlük, Merve Güner Oytun, Damla Günenç

DOI: 10.5606/fng.transplantasyon.2017.004

Issue: 2017, Volume 2 - Issue 1
0 2404

The role of angiogenesis in physiological and pathological conditions

Rasim Hamutoğlu, Ozan Önder

DOI: 10.5606/fng.transplantasyon.2017.010

Issue: 2017, Volume 2 - Issue 2
0 2962

Corneal transplantation and immunosuppressants

Pakize Nur Akkaya, Oytun Erbaş

DOI: 10.5606/dsufnjt.2019.001

Issue: 2019, Volume 4 - Issue 1-2
7290 2236

Non-small cell lung cancer and its treatment

Havvanur Akbulut, Semanur İncedayı, Özüm Atasoy

DOI: 10.5606/dsufnjt.2019.004

Issue: 2019, Volume 4 - Issue 1-2
2577 1867

Intestinal transplantation

Mine Ün, Oytun Erbaş

DOI: 10.5606/dsufnjt.2019.007

Issue: 2019, Volume 4 - Issue 1-2
2292 1982

Urinary tumor markers for diagnosis of prostate cancer

Mine Ün, Mustafa Sel

DOI: 10.5606/dsufnjt.2019.010

Issue: 2019, Volume 4 - Issue 1-2
2180 1843

Repigmentation observed in hair due to cancer immunotherapy

Esra Nur Arslan, Oytun Erbaş

DOI: 10.5606/fng.transplantasyon.2018.004

Issue: 2018, Volume 3 - Issue 1-2
3585 1602

PD-1, PD-L1 mechanism and cancer treatment

Aslı Babayakalı, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.019

Issue: 2021, Volume 6 - Issue 1-2
1165 1374

Tumor markers and clinical use

Burak Akverdi, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.023

Issue: 2021, Volume 6 - Issue 1-2
1895 2832

Alkaliptosis: A new strategy for cancer therapy

Beyza Emine Kılınç, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.024

Issue: 2021, Volume 6 - Issue 1-2
1535 1638

Bone marrow transplantation use on treatment solid tumors

İlayda Üzümcü, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.026

Issue: 2021, Volume 6 - Issue 1-2
1183 1403

Cancer cells and alpha-ketoglutarate

Yalda Sadeghian, İlayda Üzümcü, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.029

Issue: 2021, Volume 6 - Issue 1-2
1359 2101

The role of oxytocin and prolactin in breast carcinogenesis and breast cancer prognosis: A mini-review

Umut Yücel, Oytun Erbaş

DOI: 10.5606/dsufnjt.2022.3

Issue: 2022, Volume 7 - Issue 1-2
1455 1080

Post-transplant infectious complications and therapeutic approaches

Zümer Duman, Oytun Erbaş

DOI: 10.5606/dsufnjt.2022.5

Issue: 2022, Volume 7 - Issue 1-2
1940 1084

NOX-4: A key player in protecting against cancer from free radicals

Şehri Çolak, Oytun Erbaş

DOI: 10.5606/dsufnjt.2023.16

Issue: 2023, Volume 8 - Issue 1&2
1522 951

Interleukin-35: Immunosuppressive mechanisms in cancer and autoimmune diseases

Gökçen Kılınç, Oytun Erbaş

DOI: 10.5606/dsufnjt.2024.18

Issue: 2024, Volume 9 - Issue 1&2
368 404